Delivery Order SPE2DR25D7066-SPE2DR26F7ZLS
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $2,532.00 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a standard pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,715.83 on July 29, 2025, for the supply of Fluticasone Propionate HFA 44 microgram inhalers (10.6 grams). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with a contract ceiling value of $4,217.23. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract involves...
- The Defense Logistics Agency awarded a delivery order valued at $42,827.06 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 microgram inhalers (12-gram units) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for Fluticasone Propionate HFA 220 micrograms in a 12-gram inhaler, with a ceiling value of $3,269.72 and a completion date of July 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,633.78 on November 5, 2025, for the supply of Fluticasone Propionate HFA 220 mcg inhalers (12 gram units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of November 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a ceiling value of $1,236.47 and a firm fixed price structure. This delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 9, 2025, for the supply of Fluticasone Propionate HFA 110 MCG inhalers (12-gram units) with a ceiling value of $3,407.24. This is a firm fixed price delivery order with an ultimate completion date of May 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award utilized no set-aside designation and was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 MCG inhalers (12 GM) valued at $8,696.48 under a firm fixed-price contract. The award was made competitively without a set-aside designation and is scheduled for completion by December 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, leveraging its established role as a critical pharmaceutical...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZLSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 13, 2025, for the supply of Fluticasone Propionate HFA 220 mcg inhalers (12 grams) with a ceiling value of $11,178.10. This firm fixed-price delivery order, with an ultimate completion date of December 15, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through December 2026. The award involved no set-aside designation, indicating competitive procurement through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive portfolio of pharmaceutical products and medical commodities to support military and veteran healthcare systems. This specific delivery order for fluticasone propionate—a corticosteroid inhaler used in respiratory treatment—exemplifies the company's role in fulfilling DLA's broad medical supply requirements across multiple therapeutic domains. AmerisourceBergen's extensive federal contracting history and the firm fixed-price delivery order structure demonstrate its established capability to meet federal pharmaceutical procurement standards and support Defense Health Agency operations and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 12/12/25 |